FLT3 (FLK2 or STK1 or CD135) Antibody

Biological Background

When you need to evaluate FLT3 with attention to cellular organization, this antibody provides a focused option. FLT3 is a pathway component whose activation state and localization can change after stimulation. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

Following FLT3 across perturbations can help separate expression effects from compartment shifts.

Use in the Laboratory

Parallel measurement of upstream inputs and downstream readouts can sharpen interpretation of pathway behavior. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Many targets show context-dependent localization, so comparisons across matched conditions can reveal meaningful patterns.

To keep datasets interpretable, labs often document:

• time-resolved changes following stimulation or inhibition
• interaction patterns within multi-protein complexes
• localization shifts between cytoplasm, membrane, and nucleus

Version Notes

This regular format is a practical starting point when you want flexibility across sample types and iterative optimization. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. Small differences in preparation can reshape apparent localization, so interpret results in context.

When interpreting FLT3, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

As you refine hypotheses around FLT3, the regular format format helps keep conclusions tied to preparation context.